24.76
price down icon2.48%   -0.60
 
loading

Finanzdaten der Guardant Health Inc-Aktie (GH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
8.41%
155.05
143.03 137.15 128.71 126.89
Operating Expenses
37.41%
352.56
256.57 256.77 262.77 273.01
Interest Income/Expense
0.16%
0.645
0.644 0.645 0.644 0.644
Benefits Costs and Expenses
49.86%
342.64
228.64 209.43 262.01 266.22
Costs And Expenses
37.41%
352.56
256.57 256.77 262.77 273.01
Operating Income/Loss
73.95%
-197.51
-113.54 -119.62 -134.06 -146.12
Income/Loss From Continuing Operations Before Tax
119.11%
-187.58
-85.61 -72.28 -133.29 -139.33
Income Tax Expense/Benefit
210.41%
-0.541
0.49 0.496 0.24 0.602
Income/Loss From Continuing Operations After Tax
117.23%
-187.04
-86.10 -72.77 -133.53 -139.93
Net Income/Loss
117.23%
-187.04
-86.10 -72.77 -133.53 -139.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.13%
2.197
117.74 108.81 102.66 0.113
Diluted Average Shares
98.13%
2.197
117.74 108.81 102.66 0.113
Basic Earnings Per Share
121.92%
-1.62
-0.73 -0.67 -1.30 -1.37
Diluted Earnings Per Share
121.92%
-1.62
-0.73 -0.67 -1.30 -1.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$108.63
price down icon 2.17%
$319.47
price up icon 1.47%
diagnostics_research WAT
$354.99
price down icon 0.24%
diagnostics_research LH
$206.84
price down icon 1.78%
diagnostics_research MTD
$1,521.56
price up icon 0.02%
diagnostics_research IQV
$230.62
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):